Literature DB >> 2529819

Pharmacological studies on dithranol-induced irritative dermatitis in mice.

L Kemény1, M Csató, A Dobozy.   

Abstract

The effects of different pharmacological substances on dithranol-induced irritative dermatitis were studied in mice. Pretreatment of the animals with a specific platelet activating factor (PAF) antagonist, BN 52021, significantly reduced the ear swelling in a dose-dependent manner. The cyclooxygenase inhibitor indomethacin, the antihistamine clemastine, and the anti-oxidant superoxide dismutase also proved to be effective in the reduction of the dermatitis. The results provide evidence of the coinvolvement of PAF, prostaglandins, histamine, and reactive oxygen radicals in dithranol-induced irritative dermatitis in mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529819     DOI: 10.1007/bf00412983

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  17 in total

Review 1.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

Review 2.  Platelet-activating factor as a mediator of allergic disease.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

Review 3.  Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology.

Authors:  M A Warso; W E Lands
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

4.  Mechanism of anthralin inflammation. I. Dissociation of response to clobetasol and indomethacin.

Authors:  C M Lawrence; S Shuster
Journal:  Br J Dermatol       Date:  1985-07       Impact factor: 9.302

5.  Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man.

Authors:  C B Archer; C P Page; J Morley; D M MacDonald
Journal:  Br J Dermatol       Date:  1985-03       Impact factor: 9.302

6.  Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis.

Authors:  M Csatò; B M Czarnetzki
Journal:  Br J Dermatol       Date:  1988-04       Impact factor: 9.302

7.  Stimulation of phospholipase A2 activity by oxygen-derived free radicals in isolated brain capillaries.

Authors:  A M Au; P H Chan; R A Fishman
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

8.  Inhibition of dithranol inflammation by free-radical scavengers.

Authors:  M J Finnen; C M Lawrence; S Shuster
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

9.  Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.

Authors:  J Benveniste; M Chignard; J P Le Couedic; B B Vargaftig
Journal:  Thromb Res       Date:  1982-03-01       Impact factor: 3.944

10.  Isolated perfused lung histamine release, lipid peroxidation, and tissue superoxide dismutase from rats exposed to normobaric hyperoxia.

Authors:  A J Januszkiewicz; M Huntrakoon; P K Wilson; M D Faiman
Journal:  Toxicology       Date:  1986-04       Impact factor: 4.221

View more
  6 in total

Review 1.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

2.  Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice.

Authors:  L Kemény; V Trach; A Dobozy
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

3.  Release of histamine in whole blood by oxygen radicals: division between specific and unspecific processes.

Authors:  B Poch; F Gansauge; S Gansauge; T Anger; U Nilsson; M H Schoenberg; H G Beger
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

4.  Characteristics and modulation of dithranol (anthralin)-induced skin irritation in the mouse ear model.

Authors:  M Viluksela
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

5.  Topical anti-inflammatory properties of flutrimazole, a new imidazole antifungal agent.

Authors:  M Merlos; M L Vericat; J García-Rafanell; J Forn
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

6.  Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents.

Authors:  M Merlos; L A Gómez; M Giral; M L Vericat; J García-Rafanell; J Forn
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.